IBRN vs. OZEM ETF Comparison

Comparison of iShares Neuroscience and Healthcare ETF (IBRN) to Roundhill GLP-1 & Weight Loss ETF (OZEM)

IBRN

iShares Neuroscience and Healthcare ETF

IBRN Description

iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$26.17

Average Daily Volume

360

Number of Holdings ^*

9

* may have additional holdings in another (foreign) market

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$25.29

Average Daily Volume

37,622

Number of Holdings ^*

14

* may have additional holdings in another (foreign) market

Performance

Period	IBRN	OZEM
30 Days	-3.79%	-10.60%
60 Days	2.72%	-11.17%
90 Days	0.03%	-12.25%
12 Months	25.03%

0 Overlapping Holdings

	Symbol	Grade	Weight in IBRN	Weight in OZEM	Overlap

IBRN Overweight 9 Positions Relative to OZEM

	Symbol	Grade	Weight
	BHVN	D	4.87%
	PTCT	B	4.57%
	ITCI	C	4.16%
	CPRX	C	3.97%
	ARGX	B	3.9%
	XENE	D	3.86%
	AXNX	A	3.69%
	NBIX	C	3.61%
	LBPH	A	3.56%

IBRN Underweight 14 Positions Relative to OZEM

	Symbol	Grade	Weight
	NVO	F	-17.04%
	LLY	F	-14.13%
	ALT	C	-4.44%
	AZN	F	-3.99%
	VKTX	F	-3.39%
	AMGN	F	-3.26%
	PFE	F	-3.07%
	SRRK	C	-2.8%
	REGN	F	-2.4%
	RYTM	C	-2.3%
	TAK	D	-2.17%
	TERN	F	-1.97%
	CORT	B	-1.77%
	OPK	C	-1.72%

IBRN: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices

Keywords: Biopharmaceutical Cancer Disorders Epilepsy Neuroscience Biology Cardiovascular Disease Chemical Compounds Insomnia Myasthenia Organic Compounds Pain Psychiatry Schizophrenia Acne Acute Myeloid Leukemia Aging Associated Diseases Alcohol Alipogene Tiparvovec Alzheimer's Disease

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

Keywords: Biopharmaceutical Obesity Pharmaceutical Products Cancer Inflammation Biotechnology Diabetes Medicine Neuroscience S&P 500 Alzheimer's Disease Anemia Asthma Cholesterol Depressive Disorder Hormones Hypertension Life Sciences Major Depressive Disorder Medication